Research
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study
-
* Corresponding author: Andrea Morelli andrea.morelli@uniroma1.it
Critical Care 2009, 13:R130 doi:10.1186/cc7990
See related commentary by Leone, http://ccforum.com/content/13/5/192
No comments have yet been made on this article.